The activation of NLRP3 may increase the expression of NLRP3-related genes such as IL-18, IL-1β, NLRP3 and caspase-1 in lymphoma cells, thereby promoting proliferation, inhibiting apoptosis, and reducing the anti-tumor effect of dexamethasone. Here, IL1B is linked to lymphoma.